Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression

Phase 0 Completed 55 enrolled Xiyuan Hospital of China Academy of Chinese Medical Sciences

RandomizedParallel-groupDouble-blindTreatment

Summary

To explore the efficacy and safety of Jiedu Tongluo granules for post stroke depression. A randomized, double-blind, placebo-controlled clinical trial was designed. The treatment group was administered the Jiedu Tongluo granules, while the control group was administered the placebo.

Timeline

Start: 2017-04-27
Primary completion: 2017-07-07
Completion: 2018-01-24

Publications

Zhao AM, Qiu WR, Mao LJ, Ren JG, Xu L, Yao MJ, Bilinksi K, Chang D, Liu JX. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial. Trials. 2018 May 10;19(1):275. doi: 10.1186/s13063-018-2633-4.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Jiedu Tongluo granules	Traditional medicine (herbal / TCM)	3.9 mg	—

Indications

No indication recorded.